EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced positive results from a multi-center phase 2 clinical study evaluating the pharmacokinetic profile of testosterone ...
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ:ATRS) today announced that a meeting was held with the U.S. Food and Drug Administration (FDA) to discuss a registration study for the VIBEX ...
WOBURN, Mass., Dec. 12, 2024 /PRNewswire/ -- Azurity Pharmaceuticals announced today the availability of Azmiro™, the first and only FDA-approved prefilled testosterone cypionate injection. Azmiro is ...
QuickShot Testosterone is a drug-device combination that delivers testosterone enanthate via a subcutaneous (SC) auto-injector. This route of administration removes the risk of transference that is ...
-Partnership supports development and manufacturing of the PRIME NexusTM syringe-based, reusable, connected autoinjector platform -Combined expertise provides a comprehensive solution for pharma ...
Many healthcare providers regard testosterone cypionate and testosterone enanthate as interchangeable, but each has differences in their ingredients and duration of action. These differences influence ...
CROSSJECT’s ZENEO® needle-free auto-injector consistently matches depth of traditional intramuscular injections and exceeds the standards needle length of currently utilized auto-injectors Injection ...
Testosterone substitution in male hypogonadism is a recognized tool to treat symptomatic patients. Various forms of this treatment exist including a long-acting intramuscular form using testosterone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback